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ABST RACT
Diabetic foot is a severe complication of diabetes that occurs as a result
of poor glycemic control, being associated with significant morbidity
and mortality. Mortality associated with this disease is estimated at 5%
in the first 12 months, and about 42% in the next 5 years. On average, it
affects about 15% of people with diabetes during their lifetime,
including as possible manifestations neuropathy, peripheral vascular
disease, and subsequent ulceration which, if treated incorrectly, can lead
to amputation.
This paper presents a retrospective and descriptive study of patients
diagnosed and treated for diabetic foot ulcers in the Proctoven Clinic.
The study includes a group of 50 cases diagnosed with diabetic foot over
a period of 5 years, from 01.01.2017 to 31.12.2021. In this study, the
effectiveness of the modern treatment methods most frequently used in
the surgical treatment of the diabetic foot is analyzed based on several
parameters.

Introduction
Diabetic foot is a frequent and very severe complication
due to its deforming nature, having an incidence of 3-4%
among patients already diagnosed with diabetes. In addition
to the poor insulin-related mechanisms, environmental
factors such as obesity, sedentary lifestyle or unhealthy diet,
as well as genetic factors are involved in altering glucose
homeostasis [1]. A strategy that includes prevention, patient
and health care education methods, multidisciplinary
treatments of the diabetic foot, and close monitoring can
reduce the amputation rate by 49-85% [2-4].
At the same time, diabetic foot is one of the most
expensive complications of diabetes. The value of medical
services is enormous, with the overall cost estimated at
around $ 1.3 trillion in 2015. The latest studies in the UK
estimated an annual cost of over $ 1.3 billion for
diabetic foot management alone, which is about 1% of the
budget of the National Health Service [5].
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Neuropathy and ischemia are the two main pathogens
of diabetic foot, which together lead to ulceration and
neuro-arthropathy Charcot. In association with infection,
the mortality of the diabetic population increases, having
both a clinical and economic impact. Ischemia in the form
of peripheral arterial disease is an important contributor to
the diabetic foot, mainly affecting the lower limb, distal to
the knee joint. The risk of developing a diabetic foot ulcer
is between 19% and 34%, with recurrence being common
after a healed episode. Approximately 40% of patients
experience a recurrence of a diabetic ulcer within one year
of healing, about 60% within 3 years, and 65% within 5
years [6].
Shortly after diabetic foot ulcers were described in the
19th century, the most common method of treatment was
prolonged bed rest. Dr. Frederick Treves (1853–1923)
revolutionized the management of diabetic ulcers by
establishing three important principles in their treatment,
which continue to be the basis of modern care. This
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includes debridement, lowering pressure on the lesion, and
educating the patient about the peculiarities of the diabetic
foot. Added to these essential principles today are local
wound care with surgical debridement, dressings that
promote a moist wound environment, vascular assessment,
treatment of active infection and glycemic control. In
addition to these principles, multidisciplinary diabetic foot
care is now becoming a standard of therapy [7,8].
Historically, wound dressings were primarily
considered to play only a passive, protective role in the
healing process. Modern surgical therapy for the diabetic
foot was revolutionized by the discovery of observations
that wet dressings can help wounds heal more quickly. In
addition, a humid environment in the wound is also an
important factor in inducing the proliferation and migration
of fibroblasts and keratinocytes, as well as in improving the
synthesis of collagen, which leads to a reduction in scar
formation [9].
This work represents an analysis of modern methods
currently used in the treatment of patients with diabetic
foot and their impact on the quality of life of patients
diagnosed with this disease. The study also reviews the
specialized literature presenting the results obtained,
related to the long practice of other medical centers and
international literature.
The purpose of this paper is therefore to present the
results obtained through different modern treatment
methods - vacuum therapy and hydro-colloidal-absorbent
dressings - and the correlations with risk factors in the
patients of the study group, composed of patients from the
Proctoven Clinic in Sibiu.

Materials and Methods
This study is an observational, longitudinal (cohort)
retrospective study on patients admitted to the Proctoven
Clinic in Sibiu, diagnosed with diabetes. The study includes
a general group of 50 patients (carried out over a period of 5
years, from 01.01.2017 to 31.12.2021) treated using modern
surgical methods (Hydrocolloid Dressings and Vacuum
Therapy). The criteria for including patients in the study
were represented by the Wagner Classification (Table 1)
[10]. Thus, patients with grade I and II ulcers were included
in the study, and patients with III-V grade ulcers were
excluded, benefiting from classic surgical treatment.
Table 1. Wagner's classification of diabetic foot ulcers

Grade - I
Grade - II

Skin intact but bony deformities lead to
"foot at risk"
Superficial ulcer
Deeper, full thickness extension

Grade - III
Grade - IV
Grade - V

Deep abscess formation or osteomyelitis
Partial Gangrene of forefoot
Extensive Gangrene

Grade - 0
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Also, the patients involved in the study had as main
criterion for inclusion the presence of lesions in the
diabetic foot (ischemia, ulceration, gangrene, neuropathy,
callus, arteriopathy). All patients between the ages of 18
and 90, both male and female, were included in the study.
In terms of pathology, all patients had type I or type II
diabetes with a diabetic foot complication. Patients under
the age of 18 and over 90, patients in whom the data
collected were incomplete and those without diabetic foot
lesions were excluded from the study. Informed consent
was obtained for all patients included in the study, after a
reasonable disclosure [11].
For statistical analysis, Microsoft Excel Office 365
software was used for statistical calculation. The
differences were considered significant if p <0.05. Data
collection and integration was done from sources that were
extracted from the database of Proctoven Sibiu Clinic.
Based on the data collected, the analysis and comparison
of the cases that were represented in the form of tables and
figures. These results were correlated with current data
from the international literature related to complications of
diabetes in the form of diabetic foot.
Among the parameters followed in the evaluation of
patients belonging to the group are: age, demographic data
(sex, environment of origin), type of diabetes, uni or
bilateral impairment, comorbidities and risk factors
associated with the group.

Results
This study was conducted over a period of 5 years,
between 2017 and 2021, which included a number of 50
patients treated at the Proctoven Clinic. We excluded a
patient due to death during the study, death due to heart
disease, unrelated to our study. The study targets patients
diagnosed with diabetes, that is patients who have
associated complications in the area of diabetic foot. All
patients benefited from modern surgical treatment methods
(hydrocolloid dressings and vacuum therapy). For the
patients admitted during Covid-19 pandemic, a strict
adherence to specific measures to prevent dissemination of
Sars-Cov-2 infection in hospital was adopted, included but
not necessarily limited to patient testing at admission of
when respiratory signs were suspicious for Covid-19
pneumonia, and wearing complete protective personal
equipment, including FFP2 masks [12].
Regarding the general data of the patients included in
the study group (Table 2), their distribution by age groups
showed a predominance of the number of cases in the age
group 51-70 years, with 33 cases representing 66% of the
total group. This distribution was followed by the 71 - 90
years age group, represented by 14 patients. The fewest
cases in the current study were recorded in younger
patients, consisting of 3 patients in the total analyzed
group (p=0.0490).
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Table 2. General data of the patients included in the
study group.
Total number /
Percentage (%)

Parameter

Age groups

Gender
Type of diabetes
Type of foot damage
Environment origin

30 -50

3 (6%)

51- 70

33 (66%)

71- 90

14 (28%)

Male

35 (70%)

Female

15 (30%)

Type I

9 (18%)

Type II

41 (82%)

Unilateral

43 (86%)

Bilateral

7 (14%)

Rural

12 (24%)

Urban

38 (76%)

The analysis of the study group according to sex,
showed the predominance of diabetic foot in males
representing 70% of the total group (p=0.0243). Regarding
the type of diabetes, a significant number of patients
presented type II diabetes as opposed to type I, where only
9 patients were registered (p=0.0441). Following the
analysis of the data, a predominantly unilateral impairment
was observed in patients with diabetic foot with 43 cases,
representing 86% of the total group (p=0.0403). The
distribution of patients according to the environment of
origin showed a higher incidence among patients in urban
areas, which can be explained by a better accessibility to
specialized medical services.
In our study, among the modern modalities of surgical
therapy, hydro-colloidal dressings and vacuum therapy
were analyzed in patients treated in the Proctoven Clinic,
diagnosed with diabetic foot.
Due to the distinct characteristics of the different types
of lesions and each stage of wound healing, there is no
single dressing that can be applied effectively in all
situations. A careful policy regarding patient safety and
reporting the possible adverse events related to therapy was
followed [13]. The types of dressings used in our clinic
were hydrocolloid dressing and vacuum therapy.
The hydrocolloid dressing contains hydrogel combined
with a type of synthetic rubber, being a very good
absorbent and also achieves a hydration of the lesions. It
promotes healing by autolysis and promotes the formation
of granulation tissue (Figure 1, a-c). This dressing does not
cause pain at the time of change, has a hydrophobic outer
layer and can be used in the treatment of deep exudative
wounds [14-16].
The application of hydrocolloid dressings to overinfected wounds has been questioned due to the possible
hypoxic and excessively moist environment that could

potentiate autolysis of necrotic tissue and therefore
increase the risk of wound infection. These dressings are
usually applied to granular and epithelial wounds and can
therefore also be used for necrotic wounds to facilitate
wound debridement. On average, these materials can be
stored on diabetic foot ulcers for more than a week.
However, there is conflicting information on the usefulness
of hydrocolloid dressings in diabetic foot wounds, in the
case of superficial wounds, if there are no signs of infection
or if it is present in small or medium amount of exudate
[9,17]. Compared to conventional dressings, hydrocolloid
ones are considered superior in the treatment of diabetic
foot ulcers, a fact confirmed by the recent data from the
literature [18].

Figure 1. Leg ulcer treated by hydro-colloidal
dressings. a) first week; b) week 4; c) week 6.
(personal collection)
In general, the hydrogel hydrates and removes necrotic
tissue. Absorbent capacity is moderate but favors autolysis,
being used in dry, necrotic wounds or with minimal
exudate. The gel can be applied directly to wounds and
does not cause pain at the time of change and can be used
in the treatment of deep wounds.
Foam-type dressings have been developed as
alternatives to hydrocolloid dressings for application to
wounds with moderate/ high secretion, having good
antimicrobial activity and thermal insulation properties.
Film dressings are impermeable to liquids and bacteria,
have an autolytic role and cause reepithelialization of
wounds with limited exudate [15,16,19].
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Another modern method used in our clinic for the
treatment of diabetic foot is vacuum therapy (Figure 2, ab). Negative pressure therapy has dramatically changed the
care of complex diabetic foot wounds.

Table 3. Distribution of patients according to the type
of modern surgical treatment
Number of
cases

Treatment

Modern

Total

Percentage
(%)

H-C
Dressings

39

78%

Vacuum
therapy

11

22%

50

100%

Although the number of patients who received modern
surgical treatment was initially small, there is a steady
annual increase in those who opted for modern therapeutic
methods, peaking in 2021 (Figure 3).

Figure 2. Use of vacuum therapy. a) Radial
amputation with debridement and disinfection
before applying vacuum therapy; b) Sponge
application on diabetic foot (personal collection).
Compared to the standard wound care, patients with
diabetic foot injuries treated with this method were 5.9
times more likely to recover and 4.4 times less likely to
require therapy by amputation. Negative pressure therapy
was performed by providing sub atmospheric pressure
through a vacuum pump that was connected to a
specialized dressing able to maintain a clear closed
environment. It increases wound perfusion, as well as
accelerates the formation of granulation tissue, reduces
edema and reduces the biological load [20]. All these
mechanisms accelerate the wound healing by increasing
the local blood flow and decreasing the bacterial
colonization. Removing the excess fluid also removes
inflammatory cytokines, which could worsen the
healing process. At the same time, by removing the
exudate from the wound, the needs to change
the dressings were reduced. This method prevents repeated
exposure to the environment through repeated dressing
changes [21,22].
During the 5 years included in the study, 39 patients
(representing 78% of the study group) benefited from
hydro-colloidal dressings. The remaining 11 patients
received vacuum therapy, representing 22% of the study
group (p = 0.01360) as presented in the Table 3.
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Figure 3. Annual distribution of patients with
modern treatment
Out of the total number of patients who received
hydrocolloid dressings, 31 cases had a favorable evolution,
and 8 patients showed a deterioration of the local wound
translated by superinfection and the spread of ulceration.
Although used in only 11 patients in the study group,
negative pressure lesion therapy has a number of important
benefits, such as reducing the size of the wound in the
diabetic foot by increasing the mechanical traction exerted
by the subatmospheric pressure on the edges of the wound,
promoting healing in a much shorter time (Figure 4). In
addition, it reduces the number of septic complications by
healing chronic lesions, reduces the number of amputations
and decreases the number of days of hospitalization and,
therefore, the costs of hospitalization [23,24].

Figure 4. Negative pressure therapy for ulceration
in the lower-lateral third of the leg (personal
collection).
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We analyzed the risk factors in the patients included in
the study group and evaluated their impact in correlation
with the modern methods of surgical treatment applied in
our clinic. These include smoking, obesity, dyslipidemia,
age of diabetes (diabetic patients older than 5 years),
hepatic steatosis, various pre-existing cardiac pathologies
and unbalanced diabetes with HbA1C values over 7.5%.
Following the analysis of risk factors associated with
diabetic foot, the predominance of pre-existing cardiac
pathologies is observed with 36 cases, followed by obesity
with 22 cases and dyslipidemia with 10 cases. Patients with
diabetes diagnosed for over 5 years represent 18% of the
total group and those with unbalanced diabetes 16%. The
lowest cases presented as risk factors hepatic steatosis and
smoking having a share of 10%, respectively 14% of the
studied group (p = 0.0139). Out of the total number of
patients included in the group, 9 had unfavorable
evolutions following the applied treatment. An important
aspect to mention is the influence of risk factors in these
patients. All the cases that had an unfavorable evolution,
presented 5 or more associated risk factors, regardless of
the type of treatment followed (p=0.006).
In the current study, comorbidities that could accelerate
the progression to the diabetic foot and other complications
have been identified and analyzed, all of which have a
significant role in increasing patient mortality [24]. The
comorbidities encountered in the patients included in the
study group are: high blood pressure (HBP), chronic
ischemic heart disease (CIHD), heart failure (HF), chronic
kidney failure (CKD), chronic venous insufficiency (CVI)
and macroangiopathy in chronic obliterative arteriopathy
(COA). The analysis of the cases included in the study
highlighted the predominance of high blood pressure in
80% of patients (40 cases), followed by arteriopathy (27
cases) and ischemic heart disease (21 cases), each with a
percentage of 54% and 42%, respectively. Heart failure and
chronic venous insufficiency were present in a smaller
number of patients with a percentage of 30% and 20% of
the total group, respectively. The lowest cases were
recorded among patients with chronic renal failure (9
cases), representing only 18% of the group.

Discussion
The management of the diabetic foot aims to avoid
amputation, which is a mutilating method and difficult for
the patient to accept. It has been observed in various studies
that factors such as age, gender, duration of diabetes,
peripheral vascular disease or neuropathy, poor glycemic
control and renal complications may play an important role
in patients' progression to amputation [26]. The treatment
applied in the early stages of the infection can reduce the
need to perform this procedure. However, in the case of
ulcers that do not show significant signs of healing, despite

all the methods used, amputation remains the only method
of treatment [27].
An important aspect to mention is that of the 11 patients
who received vacuum therapy, only one showed an
unfavorable evolution, requiring amputation. The rest of
the patients had favorable evolutions, requiring no
additional classical surgery.
Therefore, the superiority of Vacuum therapy over
modern dressings in the treatment of diabetic foot ulcers
can be noted. We considered it necessary to correlate these
results with specialized studies to compare the
effectiveness of these two modern methods of treating
diabetic foot. In a randomized multi-center study with 342
patients, Blume et al. compared the therapy of negative
pressure lesions with lesions treated by applying Hydrogel
or Alignat dressings to diabetic foot ulcers. They found a
higher rate of closure of ulcers that were treated using
negative pressure therapy and concluded that this
therapeutic strategy is a safe and effective way to improve
the healing potential of diabetic foot ulcers. In the same
study, a significantly lower incidence of secondary
amputations was found in patients receiving negative
pressure therapy [28].
In a study conducted by Bagul et al., the effectiveness
of negative pressure therapy and that of conventional
dressings in the treatment of diabetic foot injuries were
compared [29]. The results showed that the patients who
received Vacuum therapy developed the granulation tissue
much faster (90.9%) at the end of the first week of
treatment, compared to the classic dressing where 76% of
the patients had a granulation tissue present at the end of
the first week. weeks. Finally, all patients developed
granulation tissue in the 2-nd week [29]. Hasaballah et al.
evaluated rates of complete healing of lesions in negative
pressure therapy compared to conventional dressings in
anatomically difficult areas (heel and ankle regions). The
study concluded that at the end of the 120-day period,
complete healing of diabetic foot injury was achieved for
72.3% of patients using Vacuum therapy, while only
30.8% fully recovered in patients with conventional
therapy [30].
The present study has some limitations: the limited
number of patients included in the study, and the lack of a
comparative group. Further prospective studies are needed
to document the outcomes of this novel therapeutic
approach in patients with diabetic foot ulcers.
The treatment of diabetic foot ulcers can be difficult to
manage without a basic understanding of the available
treatment options and a thorough assessment of the
characteristics of the ulcer. The current literature suggests
that if the initial treatment plan does not reduce the size of
the ulcer by 50% in four weeks, it should be re-evaluated.
The essential components of any initial or re-evaluated
treatment plan should include debridement, wet wound
289
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healing, decompression and control of infection.
Conservative options are usually used first, but if progress
stagnates, the surgical components of the treatment plan
can help reduce healing time or even promote healing. The
characteristics of a diabetic foot ulcer are important to
consider because they directly influence the choice of
treatment methods. Assessing the location, size, and depth
of the diabetic foot ulcer, the type of tissue, the presence or
absence of drainage, the duration of the ulcer, and the
vascular intake are important variables to consider when
formulating the surgical treatment plan [31-33]. Recently,
a large array of biomarkers, such a s neutrophil-tolymphocyte ratio (NLR), thrombocyte-to lymphocyte ratio
(TLR), IL-6 and procalcitonin were studied for the
predictive value in patients with DFU [34-36].
Diabetes is rarely presented as a unique pathology.
Most often the diabetic patient associates a series of
comorbidities, complications of diabetes, but also
numerous risk factors for the appearance of diabetic foot
lesions, which translate over time into an inappropriate
lifestyle [37-40]. Recent studies showed the importance
of inflammation mechanisms that underlie the
pathophysiology of cardiometabolic syndrome, including
diabetes mellitus (hyperglycemia and insulin resistance),
dyslipidemia, obesity along with visceral adiposity, and
cardiac impairment [41-43]. There are significant
disfunctions in immune responses and metabolic
regulation, that could impact wound healing. The analysis
of the data shows that all patients included in the study had
at least 2 associated risk factors, while the patients that had
unfavorable outcomes had 5 or more risk factors. This
result coincides with the study conducted by Martín-Timón
et al., which shows that obesity, heart disease and
dyslipidemia are the most common risk factors associated
with diabetes complications [44].
An important aspect to mention is that most of the
patients included in the study group presented one or more
associated comorbidities, a fact confirmed by the study
conducted by Iglay et al. They showed that most adults
diagnosed with diabetes have at least one comorbidity, and
up to 40% of them have at least three comorbidities [45].
In addition, after batch analysis, it was observed that
patients who showed unfavorable evolution, regardless of
the type of surgical treatment followed, had at least 4
associated comorbidities, mainly due to high blood
pressure, lower limb arteriopathy, chronic ischemic heart
disease and cardiac insufficiency. Studies conducted by
Piette and Huang showed that comorbidities associated
with diabetes increase the demand for medical care, the
cost of hospitalization and the frequency of medical
follow-up [46,47].
Therefore, the management of diabetic foot should be
approached in a multidisciplinary team that requires, in
addition to medical and surgical treatment, the education
290

of the patient in all aspects. Following a study by Sharma
et al., it was concluded that the only way to minimize the
morbidity of diabetic foot is to educate patients about the
modifiable risk factors and effective prevention, reducing
the chances of developing primary ulcers [48].

Conclusions
Modern surgical treatments have significantly
improved in patients with complications of diabetes by
lowering the rate of amputations. In our study, there is an
annual increase in patients who have received modern
treatment, peaking in 2021. Following the analysis, it was
observed that vacuum therapy is much more effective
compared to hydro-colloidal dressings by increasing the
number of wounds healed, reducing healing time and
reducing the risk of amputation.
Even if the vacuum therapy is more difficult to accept
by the patient (due to the fact that it relatively immobilizes
the patient through the attached technology), its benefits
make us recommend it comparing to the therapy with
hydro-colloidal absorbent dressings.
Risk factors play an important role in the occurrence of
diabetic foot lesions, but also in the healing period of
lesions, regardless of the type of modern therapy applied.

Highlights
✓

Modern surgical treatments have improved
significantly in patients with diabetes complications
resulting in decreased amputation rates.

✓

Management of associated risk factors, such as
dyslipidemia, hypertension, high HbA1C, is extremely
important in patients with diabetic foot to ensure
favorable outcomes.
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